,  —

Articles by

Vitamin B12 May Protect Nerve Cells From Alpha-synuclein Clumps, Study Suggests

Vitamin B12 can prevent the formation of and destroy alpha-synuclein aggregates in the brain, lowering their toxicity and potentially helping to alleviate Parkinson’s disease, according to a study. The study, “Vitamin B12 inhibits α-synuclein fibrillogenesis and protects against amyloid-induced cytotoxicity,” was published in the journal…

High-frequency Brain Stimulation Is Superior for Parkinson’s Patients, Study Suggests

Repetitive transcranial magnetic stimulation (rTMS), given at high or low frequency, effectively reduces motor symptoms in Parkinson’s disease patients, but the effects of high-frequency rTMS are superior and last longer, a clinical trial shows. Investigators also found that the treatment is more effective in patients with akinetic-rigid Parkinson’s — those…

Stem Cell Transplants Could Significantly Improve Parkinson’s Treatment, Study Suggests

Cell replacement therapies in which dopamine-producing stem cells are transplanted into Parkinson’s disease patients could improve motor symptoms, reducing or eliminating the need for dopaminergic medicines, a study suggests. The study, “Repairing the Brain: Cell Replacement Using Stem Cell-Based Technologies,” was published in the Journal of …

New Diagnostics for PD Might Allow Early Diagnosis, Prevention

A new way of diagnosing Parkinson’s disease based on manifestations that appear decades before motor symptoms — the current hallmarks for diagnosis — might allow early diagnosis and even prevention. The study, “From Prodromal to Overt Parkinson’s Disease: Towards a New Definition in the Year 2040,” was published in…